Related Experiment Videos
Targeting a key enzyme in cell growth: a novel therapy for cancer
Abstract:
The enzyme ribonucleotide reductase (RR) controls the synthesis of DNA precursors and thus plays a pivotal role in cell growth. Since the free-radical-containing active-site of this enzyme can be disabled by a lone electron, low-level direct electric current should have an inhibitory effect on RR and, thus, on uncontrolled cell proliferation. This hypothesis is strongly supported by the results of several cancer electrotherapy studies reported over the years.
Insights
Direct electric current can inhibit ribonucleotide reductase (RR), an enzyme crucial for cell growth. This finding supports the potential of electrotherapy for treating uncontrolled cell proliferation, such as in cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ribonucleotide reductase (RR) is essential for DNA synthesis and cell proliferation.
- The enzyme's active site contains free radicals, making it susceptible to electron interference.
Purpose of the Study:
- To investigate the potential of low-level direct electric current to inhibit RR activity.
- To explore the therapeutic implications of targeting RR with electrotherapy for cancer treatment.
Main Methods:
- The study is based on the established biochemical properties of ribonucleotide reductase.
- It reviews and synthesizes findings from existing cancer electrotherapy research.
Main Results:
- A lone electron can disable the free-radical-containing active site of RR.
- Low-level direct electric current is hypothesized to inhibit RR.
- Previous electrotherapy studies provide supporting evidence for this hypothesis.
Conclusions:
- Direct electric current shows promise as an inhibitory agent against RR.
- Electrotherapy may offer a viable strategy for controlling uncontrolled cell proliferation in cancer.